PL3567099T3 - Populacje komórek nerkowych i ich zastosowania - Google Patents

Populacje komórek nerkowych i ich zastosowania

Info

Publication number
PL3567099T3
PL3567099T3 PL19168775T PL19168775T PL3567099T3 PL 3567099 T3 PL3567099 T3 PL 3567099T3 PL 19168775 T PL19168775 T PL 19168775T PL 19168775 T PL19168775 T PL 19168775T PL 3567099 T3 PL3567099 T3 PL 3567099T3
Authority
PL
Poland
Prior art keywords
cell populations
renal cell
renal
populations
cell
Prior art date
Application number
PL19168775T
Other languages
English (en)
Inventor
Joydeep Basu
Kelly Guthrie
Dominic JUSTEWICZ
Teresa BURNETTE
Andrew Bruce
Russell Kelley
John W. Ludlow
Original Assignee
Prokidney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prokidney filed Critical Prokidney
Publication of PL3567099T3 publication Critical patent/PL3567099T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/02—Aminoacyltransferases (2.3.2)
    • C12Y203/02002—Gamma-glutamyltransferase (2.3.2.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
PL19168775T 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania PL3567099T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261718150P 2012-10-24 2012-10-24
US201361876616P 2013-09-11 2013-09-11
PCT/US2013/066707 WO2014066699A1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof
EP19168775.5A EP3567099B1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof
EP13786132.4A EP2912165B1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof

Publications (1)

Publication Number Publication Date
PL3567099T3 true PL3567099T3 (pl) 2021-11-29

Family

ID=49517782

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19168775T PL3567099T3 (pl) 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania
PL13786132T PL2912165T3 (pl) 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13786132T PL2912165T3 (pl) 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania

Country Status (18)

Country Link
US (4) US20150246073A1 (pl)
EP (3) EP3567099B1 (pl)
JP (2) JP6509119B2 (pl)
KR (5) KR20240096798A (pl)
CN (3) CN110184232B (pl)
AU (3) AU2013334276B2 (pl)
BR (2) BR122020018576B1 (pl)
CA (2) CA2889270A1 (pl)
DK (2) DK3567099T3 (pl)
ES (2) ES2744979T3 (pl)
HK (1) HK1215448A1 (pl)
HU (2) HUE054882T2 (pl)
NZ (2) NZ707873A (pl)
PL (2) PL3567099T3 (pl)
PT (1) PT2912165T (pl)
RU (1) RU2702721C2 (pl)
SI (1) SI2912165T1 (pl)
WO (1) WO2014066699A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240096798A (ko) 2012-10-24 2024-06-26 인리젠 신장 세포 모집단 및 이의 용도
US11123372B2 (en) * 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CA3031320A1 (en) * 2016-07-29 2018-02-01 Deepak Jain Bioactive renal cells for the treatment of chronic kidney disease
MX2019011545A (es) * 2017-03-31 2020-07-14 Deepak Jain Composiciones celulares y de andamio inyectables.
CA3065790A1 (en) * 2017-06-21 2018-12-27 Timothy A. Bertram Immunoprivileged bioactive renal cells for the treatment of kidney disease
JP7061766B2 (ja) * 2017-09-20 2022-05-02 学校法人同志社 Ｄｊ－１タンパク質産生促進用組成物
CN109266616A (zh) * 2018-08-21 2019-01-25 山西省人民医院 一种稳定表达aqp2蛋白的人源化小鼠足细胞模型及其构建方法和应用
CA3108729A1 (en) * 2018-08-31 2020-03-05 Timothy Bertram Compositions comprising cell-derived vesicles and uses thereof
AU2020266168A1 (en) * 2019-05-02 2021-12-02 Prokidney Treatment of kidney disease in subjects with kidney and/or urinary tract anomalies
IL295156A (en) * 2020-01-28 2022-09-01 Kidneycure Ltd Process for production of kidney cells and treatment
CN116240161B (zh) * 2023-02-27 2024-05-10 四川大学华西医院 具有肾脏损伤修复作用的细胞外囊泡制备方法及应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
CA2046830C (en) 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US6346274B1 (en) 1995-03-10 2002-02-12 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
CA2307567C (en) 1997-10-31 2009-01-20 Children's Medical Center Corporation Polymer matrix/cell construct for bladder reconstruction
EP1071400B1 (en) 1998-04-20 2004-11-03 Genzyme Corporation Drug delivery of proteins from polymeric blends
DE19933582A1 (de) 1999-07-17 2001-01-18 Gerhard Rosenberger Vorrichtung zum Aufnehmen von Werkstücken und/oder Werkzeugen
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US7197470B1 (en) 2000-10-11 2007-03-27 Buzzmetrics, Ltd. System and method for collection analysis of electronic discussion methods
CN1630819A (zh) 2001-04-03 2005-06-22 默克专利有限公司 肾细胞癌肿瘤标记
AU2003207459A1 (en) * 2002-01-03 2003-07-24 The Scripps Research Institute Cancer-associated epitope
CA2479254A1 (en) 2002-03-22 2003-10-02 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for renal disease
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20040139072A1 (en) 2003-01-13 2004-07-15 Broder Andrei Z. System and method for locating similar records in a database
US20050241012A1 (en) * 2003-10-17 2005-10-27 Nigam Sanjay K Multigene profiling in the kidney to tailor drug therapy
US20050108384A1 (en) 2003-10-23 2005-05-19 Lambert John R. Analysis of message sequences
US7788087B2 (en) 2005-03-01 2010-08-31 Microsoft Corporation System for processing sentiment-bearing text
US20080161231A1 (en) * 2005-03-18 2008-07-03 Kintan Pty. Ltd. Methods and compositions for promoting organ development
WO2006117889A1 (ja) * 2005-04-28 2006-11-09 Stemcell Institute Inc. 移植用臓器の調製方法
CA2641733C (en) 2006-02-10 2015-03-31 Tengion, Inc. Scaffolds for organ reconstruction and augmentation
WO2007101263A2 (en) 2006-02-28 2007-09-07 Buzzlogic, Inc. Social analytics system and method for analyzing conversations in social media
CN101595212B (zh) * 2006-10-12 2014-04-30 伊西康公司 肾源细胞及在组织修复和再生中的使用方法
US8048636B2 (en) * 2007-03-05 2011-11-01 Northshore University Healthsystem Methods of screening for modulators of h2-calponin activity
CN103865871A (zh) * 2007-06-08 2014-06-18 韦克福里斯特大学健康科学院 治疗肾功能衰竭的选择性细胞疗法
RU2373942C2 (ru) * 2007-12-26 2009-11-27 Федеральное государственное учреждение "Научный Центр акушерства, гинекологии и перинатологии Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения хронической и острой почечной недостаточности с помощью фетальных стволовых и прогениторных клеток
SG10201609507TA (en) 2008-02-01 2017-01-27 Gen Hospital Corp Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
EP3461507A1 (en) 2008-11-04 2019-04-03 inRegen Cell-scaffold constructs
EP2186883A1 (en) * 2008-11-04 2010-05-19 Fresenius Medical Care An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
NZ593207A (en) 2008-11-12 2012-10-26 Tengion Inc Isolated renal cells and uses thereof
WO2011017678A1 (en) * 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting obstructive uropathy and associated disorders
NZ599596A (en) * 2009-11-12 2014-01-31 Tengion Inc Rational design of regenerative medicine products
SG183171A1 (en) 2010-02-04 2012-09-27 Agency Science Tech & Res Use of novel markers of pluripotent stem cells
NZ630187A (en) 2010-05-03 2016-04-29 Regenmed Cayman Ltd Smooth muscle cell constructs
EP2569418B1 (en) * 2010-05-12 2016-11-02 RegenMed (Cayman) Ltd. Bioactive renal cells
WO2011156642A1 (en) 2010-06-11 2011-12-15 Tengion, Inc. Erythropoietin-expressing adipose cell populations
KR102302069B1 (ko) 2010-11-10 2021-09-14 인리젠 장기 확대를 위한 주사가능 제제
WO2013049856A2 (en) * 2011-09-30 2013-04-04 Hare Joshue M Renal stem cells isolated from kidney
WO2013067498A1 (en) 2011-11-04 2013-05-10 Tengion, Inc. Drug screening and potency assays
US9213997B2 (en) 2012-10-24 2015-12-15 Moodwire, Inc. Method and system for social media burst classifications
KR20240096798A (ko) 2012-10-24 2024-06-26 인리젠 신장 세포 모집단 및 이의 용도
US20160101133A1 (en) * 2013-05-08 2016-04-14 Regenmedtx, Llc Organoids comprising isolated renal cells and use thereof
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CA3065790A1 (en) * 2017-06-21 2018-12-27 Timothy A. Bertram Immunoprivileged bioactive renal cells for the treatment of kidney disease
US20240003878A1 (en) * 2020-11-13 2024-01-04 Timothy A. Bertram Enriched bioactive renal cell populations, characteristics and uses thereof

Also Published As

Publication number Publication date
HK1215448A1 (zh) 2016-08-26
ES2744979T3 (es) 2020-02-27
BR112015009042A2 (pt) 2017-07-04
CN110184232B (zh) 2023-10-20
NZ707873A (en) 2019-01-25
HUE046176T2 (hu) 2020-02-28
KR20210018965A (ko) 2021-02-18
EP3901251A1 (en) 2021-10-27
KR20220150419A (ko) 2022-11-10
US20200101112A1 (en) 2020-04-02
CN104937095B (zh) 2019-06-07
EP3567099B1 (en) 2021-04-21
DK3567099T3 (da) 2021-06-07
CA2889270A1 (en) 2014-05-01
US20150246073A1 (en) 2015-09-03
JP6509119B2 (ja) 2019-05-08
PL2912165T3 (pl) 2020-01-31
BR122020018576B1 (pt) 2022-07-05
CN104937095A (zh) 2015-09-23
AU2013334276B2 (en) 2019-07-04
US20170281684A1 (en) 2017-10-05
ES2876177T3 (es) 2021-11-12
AU2013334276A1 (en) 2015-05-14
JP2016504017A (ja) 2016-02-12
NZ741724A (en) 2020-02-28
RU2019118791A (ru) 2019-07-11
PT2912165T (pt) 2019-09-26
CN110184232A (zh) 2019-08-30
CN117660296A (zh) 2024-03-08
CA3240629A1 (en) 2014-05-01
ES2744979T8 (es) 2020-04-28
US20220347221A1 (en) 2022-11-03
JP2019141067A (ja) 2019-08-29
KR102460536B1 (ko) 2022-10-31
KR20200113287A (ko) 2020-10-06
RU2015119514A (ru) 2016-12-20
JP6696023B2 (ja) 2020-05-20
US11369639B2 (en) 2022-06-28
RU2702721C2 (ru) 2019-10-09
KR102674303B1 (ko) 2024-06-12
EP3567099A1 (en) 2019-11-13
KR102160725B1 (ko) 2020-09-29
KR20240096798A (ko) 2024-06-26
AU2019204178A1 (en) 2019-07-04
US10363274B2 (en) 2019-07-30
DK2912165T3 (da) 2019-09-16
BR112015009042B1 (pt) 2021-10-19
BR112015009042A8 (pt) 2017-10-10
EP2912165B1 (en) 2019-06-19
HUE054882T2 (hu) 2021-10-28
SI2912165T1 (sl) 2019-11-29
KR102215476B1 (ko) 2021-02-17
AU2019204178B2 (en) 2021-11-18
KR20150085818A (ko) 2015-07-24
AU2022201010A1 (en) 2022-03-03
EP2912165A1 (en) 2015-09-02
WO2014066699A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
HK1251033A1 (zh) 全細胞分析和方法
HK1213016A1 (zh) 細胞調節化合物及其用途
HK1211623A1 (en) Cell lines
HK1215448A1 (zh) 腎細胞群及其用途
EP2862225A4 (en) DESIGN OF A REDOX FLUX BATTERY WITH SEVERAL MEMBRANES AND SEVERAL ELECTRODES
EP2919313A4 (en) SOLID ELECTROLYTE
EP2858140A4 (en) BATTERY BOX
EP2863471A4 (en) SECONDARY BATTERY SYSTEM AND ERROR DETECTION SYSTEM FOR SECONDARY BATTERY
AU347859S (en) Battery
AU346864S (en) Battery
EP2824749A4 (en) BATTERY WITH A COATED STRUCTURE
HK1207662A1 (en) Cell suspension and use thereof
EP2911230A4 (en) CELL
EP2939306A4 (en) DRUMS
HK1199148A1 (en) Electrochemical cell
EP2831949A4 (en) SODIUM OXYGEN CELLS
HK1252801A1 (zh) 經修飾的紅細胞前體細胞及其用途
IL238880B (en) Systems and methods for electrochemical separation
HK1210356A1 (en) Cell change in discontinuous mode
EP2899789A4 (en) OXYDOREDUCTION CIRCULATION BATTERY
EP2874200A4 (en) FLAT BATTERY
EP2911227A4 (en) FLAT BATTERY
EP2863459A4 (en) FLAT CELL
EP2864472A4 (en) MATERIALS AND METHODS FOR TREATING CELLULAR POPULATIONS
EP2939294A4 (en) DRUMS